| Attribute |
Value |
| 52 Week Change |
-0.14054054 |
| Address1 |
4,600 South Syracuse Street |
| Address2 |
Suite 900 |
| All Time High |
5,627,700.0 |
| All Time Low |
0.53 |
| Ask |
1.95 |
| Ask Size |
2 |
| Audit Risk |
10 |
| Average Analyst Rating |
1.3 - Strong Buy |
| Average Daily Volume10 Day |
2,145,700 |
| Average Daily Volume3 Month |
2,508,979 |
| Average Volume |
2,508,979 |
| Average Volume10Days |
2,145,700 |
| Beta |
1.62 |
| Bid |
1.17 |
| Bid Size |
2 |
| Board Risk |
7 |
| Book Value |
0.701 |
| City |
Denver |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
10 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
1.59 |
| Current Ratio |
24.258 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
1.63 |
| Day Low |
1.51 |
| Display Name |
Palisade Bio |
| Dividend Date |
1,563,408,000 |
| Dividend Yield |
0.0 |
| Earnings Timestamp End |
1,755,288,000 |
| Earnings Timestamp Start |
1,754,942,400 |
| Ebitda |
-35,346,500 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-4.298 |
| Enterprise To Revenue |
303.84 |
| Enterprise Value |
151,920,192 |
| Eps Current Year |
-0.22375 |
| Eps Forward |
-0.28375 |
| Eps Trailing Twelve Months |
0.6 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.8648 |
| Fifty Day Average Change |
-0.27479994 |
| Fifty Day Average Change Percent |
-0.14736162 |
| Fifty Two Week Change Percent |
-14.054054 |
| Fifty Two Week High |
2.86 |
| Fifty Two Week High Change |
-1.2699999 |
| Fifty Two Week High Change Percent |
-0.4440559 |
| Fifty Two Week Low |
1.32 |
| Fifty Two Week Low Change |
0.26999998 |
| Fifty Two Week Low Change Percent |
0.20454544 |
| Fifty Two Week Range |
1.32 - 2.86 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,175,261,400,000 |
| Float Shares |
135,425,651 |
| Forward Eps |
-0.28375 |
| Forward P E |
-5.603524 |
| Free Cashflow |
-8,654,125 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
14 |
| Fullday Change |
0.05000007 |
| Fullday Change Percent |
3.246758 |
| Fullday Price |
1.59 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
1.0 |
| Gross Profits |
500,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.04156 |
| Held Percent Institutions |
1.01348 |
| Implied Shares Outstanding |
174,270,558 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,712,534,400 |
| Last Split Factor |
1:15 |
| Long Business Summary |
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its lead clinical product candidate includes PALI-2108, which is in phase 1b clinical trial to treat patients with inflammatory bowel disease, including ulcerative colitis and Fibrostenotic Crohn's disease. The company has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company was founded in 2001 and is headquartered in Denver, Colorado. |
| Long Name |
Palisade Bio, Inc. |
| Market |
us_market |
| Market Cap |
277,090,208 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_244367385 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-13 |
| Net Income To Common |
-31,941,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
281,769,951 |
| Number Of Analyst Opinions |
10 |
| Open |
1.5253 |
| Operating Cashflow |
-18,190,000 |
| Operating Margins |
-23.396002 |
| Overall Risk |
10 |
| Payout Ratio |
0.0 |
| Phone |
858 704 4900 |
| Prev Name |
Seneca Biopharma, Inc. |
| Previous Close |
1.54 |
| Price Eps Current Year |
-7.1061454 |
| Price Hint |
4 |
| Price To Book |
2.2681885 |
| Price To Sales Trailing12 Months |
554.1804 |
| Profit Margins |
0.0 |
| Quick Ratio |
23.956 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.3 |
| Region |
US |
| Regular Market Change |
0.0500001 |
| Regular Market Change Percent |
3.24676 |
| Regular Market Day High |
1.63 |
| Regular Market Day Low |
1.51 |
| Regular Market Day Range |
1.51 - 1.63 |
| Regular Market Open |
1.5253 |
| Regular Market Previous Close |
1.54 |
| Regular Market Price |
1.59 |
| Regular Market Time |
1,791,835,200 |
| Regular Market Volume |
1,571,663 |
| Return On Assets |
-0.32979 |
| Return On Equity |
-0.51365 |
| Revenue Per Share |
0.003 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
9 |
| Shares Outstanding |
174,270,558 |
| Shares Percent Shares Out |
0.17799999 |
| Shares Short |
31,015,282 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
30,902,111 |
| Short Name |
Palisade Bio, Inc. |
| Short Percent Of Float |
0.17799999 |
| Short Ratio |
8.47 |
| Source Interval |
15 |
| State |
CO |
| Symbol |
PALI |
| Target High Price |
25.0 |
| Target Low Price |
5.0 |
| Target Mean Price |
9.8 |
| Target Median Price |
7.5 |
| Total Cash |
125,172,000 |
| Total Cash Per Share |
0.718 |
| Total Debt |
0 |
| Total Revenue |
500,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
0.6 |
| Trailing P E |
2.6499999 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
1.90595 |
| Two Hundred Day Average Change |
-0.31594992 |
| Two Hundred Day Average Change Percent |
-0.1657703 |
| Type Disp |
Equity |
| Volume |
1,571,663 |
| Website |
https://www.palisadebio.com |
| Zip |
80,237 |